QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the transition period from________ to________ . |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
☒ | Accelerated filer | ☐ | |||||||||
Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
Emerging growth company |
Class | Shares Outstanding | Date | ||||||||||||
Common stock, $1.00 par value | June 30, 2024 |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net sales | $ | $ | $ | $ | |||||||||||||||||||
Cost of sales | |||||||||||||||||||||||
Gross profit | |||||||||||||||||||||||
Selling, general and administrative expenses | |||||||||||||||||||||||
Other (income) expense, net | |||||||||||||||||||||||
Operating profit | |||||||||||||||||||||||
Non-service related postretirement costs | |||||||||||||||||||||||
Interest (income) expense, net | |||||||||||||||||||||||
Income before income taxes | |||||||||||||||||||||||
Provision for income taxes | |||||||||||||||||||||||
Net income including noncontrolling interests | |||||||||||||||||||||||
Less: Net income attributable to noncontrolling interests | |||||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | $ | $ | $ | $ | |||||||||||||||||||
Earnings per common share, basic | $ | $ | $ | $ | |||||||||||||||||||
Earnings per common share, diluted | $ | $ | $ | $ | |||||||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net income including noncontrolling interests | $ | $ | $ | $ | |||||||||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Cumulative translation adjustments | ( | ( | |||||||||||||||||||||
Retirement plans and other retiree benefit adjustments | |||||||||||||||||||||||
Gains (losses) on cash flow hedges | ( | ( | |||||||||||||||||||||
Total Other comprehensive income (loss), net of tax | ( | ( | |||||||||||||||||||||
Total Comprehensive income including noncontrolling interests | |||||||||||||||||||||||
Less: Net income attributable to noncontrolling interests | |||||||||||||||||||||||
Less: Cumulative translation adjustments attributable to noncontrolling interests | ( | ( | ( | ( | |||||||||||||||||||
Total Comprehensive income attributable to noncontrolling interests | |||||||||||||||||||||||
Total Comprehensive income attributable to Colgate-Palmolive Company | $ | $ | $ | $ |
June 30, 2024 | December 31, 2023 | ||||||||||
Assets | |||||||||||
Current Assets | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Receivables (net of allowances of $ | |||||||||||
Inventories | |||||||||||
Other current assets | |||||||||||
Total current assets | |||||||||||
Property, plant and equipment: | |||||||||||
Cost | |||||||||||
Less: Accumulated depreciation | ( | ( | |||||||||
Goodwill | |||||||||||
Other intangible assets, net | |||||||||||
Deferred income taxes | |||||||||||
Other assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities and Shareholders’ Equity | |||||||||||
Current Liabilities | |||||||||||
Notes and loans payable | $ | $ | |||||||||
Current portion of long-term debt | |||||||||||
Accounts payable | |||||||||||
Accrued income taxes | |||||||||||
Other accruals | |||||||||||
Total current liabilities | |||||||||||
Long-term debt | |||||||||||
Deferred income taxes | |||||||||||
Other liabilities | |||||||||||
Total liabilities | |||||||||||
Shareholders’ Equity | |||||||||||
Common stock, $ | |||||||||||
Additional paid-in capital | |||||||||||
Retained earnings | |||||||||||
Accumulated other comprehensive income (loss) | ( | ( | |||||||||
Treasury stock, at cost | ( | ( | |||||||||
Total Colgate-Palmolive Company shareholders’ equity | |||||||||||
Noncontrolling interests | |||||||||||
Total equity | |||||||||||
Total liabilities and equity | $ | $ |
Six Months Ended | |||||||||||
June 30, | |||||||||||
2024 | 2023 | ||||||||||
Operating Activities | |||||||||||
Net income including noncontrolling interests | $ | $ | |||||||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | |||||||||||
Depreciation and amortization | |||||||||||
ERISA litigation matter | |||||||||||
Restructuring and termination benefits, net of cash | ( | ||||||||||
Stock-based compensation expense | |||||||||||
Deferred income taxes | ( | ( | |||||||||
Cash effects of changes in: | |||||||||||
Receivables | ( | ( | |||||||||
Inventories | ( | ||||||||||
Accounts payable and other accruals | |||||||||||
Other non-current assets and liabilities | |||||||||||
Net cash provided by (used in) operations | |||||||||||
Investing Activities | |||||||||||
Capital expenditures | ( | ( | |||||||||
Purchases of marketable securities and investments | ( | ( | |||||||||
Proceeds from sale of marketable securities and investments | |||||||||||
Other investing activities | ( | ||||||||||
Net cash provided by (used in) investing activities | ( | ( | |||||||||
Financing Activities | |||||||||||
Short-term borrowing (repayment) less than 90 days, net | ( | ||||||||||
Principal payments of debt | ( | ( | |||||||||
Proceeds from issuance of debt | |||||||||||
Dividends paid | ( | ( | |||||||||
Purchases of treasury shares | ( | ( | |||||||||
Proceeds from exercise of stock options | |||||||||||
Other financing activities | ( | ||||||||||
Net cash provided by (used in) financing activities | ( | ( | |||||||||
Effect of exchange rate changes on Cash and cash equivalents | ( | ( | |||||||||
Net increase (decrease) in Cash and cash equivalents | |||||||||||
Cash and cash equivalents at beginning of the period | |||||||||||
Cash and cash equivalents at end of the period | $ | $ | |||||||||
Supplemental Cash Flow Information | |||||||||||
Income taxes paid | $ | $ | |||||||||
Interest paid | $ | $ |
Three Months Ended June 30, 2024 | |||||||||||||||||||||||||||||||||||||||||
Colgate-Palmolive Company Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Unearned Compensation | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss)(1) | Noncontrolling Interests | |||||||||||||||||||||||||||||||||||
Balance, March 31, 2024 | $ | $ | $ | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||
Dividends ($ | — | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Shares issued for stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Shares issued for restricted stock units | — | ( | — | — | — | — | |||||||||||||||||||||||||||||||||||
Treasury stock acquired | — | — | — | ( | — | — | — | ||||||||||||||||||||||||||||||||||
Other | — | — | ( | — | — | — | |||||||||||||||||||||||||||||||||||
Balance, June 30, 2024 | $ | $ | $ | $ | ( | $ | $ | ( | $ |
Three Months Ended June 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
Colgate-Palmolive Company Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Unearned Compensation | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss)(1) | Noncontrolling Interests | |||||||||||||||||||||||||||||||||||
Balance, March 31, 2023 | $ | $ | $ | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | — | — | — | — | — | ( | |||||||||||||||||||||||||||||||||||
Dividends ($ | — | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Shares issued for stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Shares issued for restricted stock units | — | ( | — | — | — | — | |||||||||||||||||||||||||||||||||||
Treasury stock acquired | — | — | — | ( | — | — | — | ||||||||||||||||||||||||||||||||||
Other | — | — | ( | — | — | — | |||||||||||||||||||||||||||||||||||
Balance, June 30, 2023 | $ | $ | $ | $ | ( | $ | $ | ( | $ |
Six Months Ended June 30, 2024 | |||||||||||||||||||||||||||||||||||||||||
Colgate-Palmolive Company Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Unearned Compensation | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss)(1) | Noncontrolling Interests | |||||||||||||||||||||||||||||||||||
Balance, December 31, 2023 | $ | $ | $ | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | — | — | — | — | — | ( | ( | ||||||||||||||||||||||||||||||||||
Dividends ($ | — | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Shares issued for stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Shares issued for restricted stock units | — | ( | — | — | — | — | |||||||||||||||||||||||||||||||||||
Treasury stock acquired | — | — | — | ( | — | — | — | ||||||||||||||||||||||||||||||||||
Other | — | — | ( | — | — | ||||||||||||||||||||||||||||||||||||
Balance, June 30, 2024 | $ | $ | $ | $ | ( | $ | $ | ( | $ |
Six Months Ended June 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
Colgate-Palmolive Company Shareholders’ Equity | |||||||||||||||||||||||||||||||||||||||||
Common Stock | Additional Paid-in Capital | Unearned Compensation | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss)(1) | Noncontrolling Interests | |||||||||||||||||||||||||||||||||||
Balance, December 31, 2022 | $ | $ | $ | ( | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | — | — | — | — | — | ( | |||||||||||||||||||||||||||||||||||
Dividends ($ | — | — | — | — | ( | — | ( | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Shares issued for stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Shares issued for restricted stock units | — | ( | — | — | — | — | |||||||||||||||||||||||||||||||||||
Treasury stock acquired | — | — | — | ( | — | — | — | ||||||||||||||||||||||||||||||||||
Other | — | ( | — | — | — | ||||||||||||||||||||||||||||||||||||
Balance, June 30, 2023 | $ | $ | $ | $ | ( | $ | $ | ( | $ |
Six Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
Gross Profit | $ | $ | |||||||||
Selling, general and administrative expenses | |||||||||||
Other (income) expense, net | |||||||||||
Non-service related postretirement costs | |||||||||||
Total 2022 Global Productivity Initiative charges, pretax | $ | $ | |||||||||
Total 2022 Global Productivity Initiative charges, aftertax | $ | $ |
Six Months Ended June 30, | Program-to-date Accumulated Charges | ||||||||||||||||
2024 | 2023 | ||||||||||||||||
North America | % | % | % | ||||||||||||||
Latin America | % | % | % | ||||||||||||||
Europe | % | % | % | ||||||||||||||
Asia Pacific | % | % | % | ||||||||||||||
Africa/Eurasia | % | % | % | ||||||||||||||
Hill's Pet Nutrition | % | % | % | ||||||||||||||
Corporate | % | % | % | ||||||||||||||
Total | % | % | % |
Cumulative Charges | |||||
as of June 30, 2024 | |||||
Employee-Related Costs | $ | ||||
Incremental Depreciation | |||||
Asset Impairments | |||||
Other | |||||
Total | $ |
Six Months Ended June 30, 2024 | ||||||||||||||||||||||||||||||||
Employee-Related Costs | Incremental Depreciation | Asset Impairments | Other | Total | ||||||||||||||||||||||||||||
Balance at December 31, 2023 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Charges | ||||||||||||||||||||||||||||||||
Cash Payments | ( | ( | ( | |||||||||||||||||||||||||||||
Charges against assets | ( | ( | ||||||||||||||||||||||||||||||
Foreign exchange | ( | ( | ||||||||||||||||||||||||||||||
Balance at June 30, 2024 | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
June 30, 2024 | December 31, 2023 | ||||||||||
Raw materials and supplies | $ | $ | |||||||||
Work-in-process | |||||||||||
Finished goods | |||||||||||
Total Inventories, net | $ | $ | |||||||||
Non-current inventory, net | $ | ( | $ | ( | |||||||
Current Inventories, net | $ | $ |
Three Months Ended | |||||||||||||||||||||||||||||||||||
June 30, 2024 | June 30, 2023 | ||||||||||||||||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | Shares (millions) | Per Share | Net income attributable to Colgate-Palmolive Company | Shares (millions) | Per Share | ||||||||||||||||||||||||||||||
Basic EPS | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
Stock options and restricted stock units | |||||||||||||||||||||||||||||||||||
Diluted EPS | $ | $ | $ | $ |
Six Months Ended | |||||||||||||||||||||||||||||||||||
June 30, 2024 | June 30, 2023 | ||||||||||||||||||||||||||||||||||
Net income attributable to Colgate-Palmolive Company | Shares (millions) | Per Share | Net income attributable to Colgate-Palmolive Company | Shares (millions) | Per Share | ||||||||||||||||||||||||||||||
Basic EPS | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
Stock options and restricted stock units | |||||||||||||||||||||||||||||||||||
Diluted EPS | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||
Cumulative translation adjustments, pre-tax | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||
Tax amounts | ( | ( | ( | |||||||||||||||||||||||
Cumulative translation adjustments, net of tax | ( | ( | ||||||||||||||||||||||||
Pension and other benefits: | ||||||||||||||||||||||||||
Net actuarial gain (loss), prior service costs and settlements during the period | ( | ( | ||||||||||||||||||||||||
Amortization of net actuarial loss, transition and prior service costs(1) | ||||||||||||||||||||||||||
Retirement Plan and other retiree benefit adjustments, pre-tax | ||||||||||||||||||||||||||
Tax amounts | ( | ( | ( | |||||||||||||||||||||||
Retirement Plan and other retiree benefit adjustments, net of tax | ||||||||||||||||||||||||||
Cash flow hedges: | ||||||||||||||||||||||||||
Unrealized gains (losses) on cash flow hedges | ( | |||||||||||||||||||||||||
Reclassification of (gains) losses into net earnings on cash flow hedges(2) | ( | |||||||||||||||||||||||||
Gains (losses) on cash flow hedges, pre-tax | ( | ( | ||||||||||||||||||||||||
Tax amounts | ||||||||||||||||||||||||||
Gains (losses) on cash flow hedges, net of tax | ( | ( | ||||||||||||||||||||||||
Total Other comprehensive income (loss), net of tax | $ | ( | $ | $ | ( | $ |
Three Months Ended June 30, | |||||||||||||||||||||||||||||||||||
Pension Benefits | Other Retiree Benefits | ||||||||||||||||||||||||||||||||||
United States | International | ||||||||||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||||||
Service cost | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Interest cost | |||||||||||||||||||||||||||||||||||
Expected return on plan assets | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Amortization of actuarial loss (gain) | ( | ( | |||||||||||||||||||||||||||||||||
Net periodic benefit cost | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Other postretirement charges | |||||||||||||||||||||||||||||||||||
Total pension cost | $ | $ | $ | $ | $ | $ |
Six Months Ended June 30, | |||||||||||||||||||||||||||||||||||
Pension Benefits | Other Retiree Benefits | ||||||||||||||||||||||||||||||||||
United States | International | ||||||||||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||||||
Service cost | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Interest cost | |||||||||||||||||||||||||||||||||||
Expected return on plan assets | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Amortization of actuarial loss (gain) | ( | ( | |||||||||||||||||||||||||||||||||
Net periodic benefit cost | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Other postretirement charges | |||||||||||||||||||||||||||||||||||
ERISA litigation matter | |||||||||||||||||||||||||||||||||||
Total pension cost | $ | $ | $ | $ | $ | $ |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net sales | |||||||||||||||||||||||
Oral, Personal and Home Care | |||||||||||||||||||||||
North America | $ | $ | $ | $ | |||||||||||||||||||
Latin America | |||||||||||||||||||||||
Europe | |||||||||||||||||||||||
Asia Pacific | |||||||||||||||||||||||
Africa/Eurasia | |||||||||||||||||||||||
Total Oral, Personal and Home Care | |||||||||||||||||||||||
Pet Nutrition | |||||||||||||||||||||||
Total Net sales | $ | $ | $ | $ |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net sales | |||||||||||||||||||||||
Oral Care | % | % | % | % | |||||||||||||||||||
Personal Care | % | % | % | % | |||||||||||||||||||
Home Care | % | % | % | % | |||||||||||||||||||
Pet Nutrition | % | % | % | % | |||||||||||||||||||
Total Net sales | % | % | % | % |
Three Months Ended | Six Months Ended | ||||||||||||||||||||||
June 30, | June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Operating profit | |||||||||||||||||||||||
Oral, Personal and Home Care | |||||||||||||||||||||||
North America | $ | $ | $ | $ | |||||||||||||||||||
Latin America | |||||||||||||||||||||||
Europe | |||||||||||||||||||||||
Asia Pacific | |||||||||||||||||||||||
Africa/Eurasia | |||||||||||||||||||||||
Total Oral, Personal and Home Care | |||||||||||||||||||||||
Pet Nutrition | |||||||||||||||||||||||
Corporate | ( | ( | ( | ( | |||||||||||||||||||
Total Operating profit | $ | $ | $ | $ |
Assets | Liabilities | ||||||||||||||||||||||||||||||||||
Account | Fair Value | Account | Fair Value | ||||||||||||||||||||||||||||||||
Designated derivative instruments | June 30, 2024 | December 31, 2023 | June 30, 2024 | December 31, 2023 | |||||||||||||||||||||||||||||||
Foreign currency contracts | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
Commodity contracts | |||||||||||||||||||||||||||||||||||
Total designated | $ | $ | $ | $ | |||||||||||||||||||||||||||||||
Other financial instruments | |||||||||||||||||||||||||||||||||||
Marketable securities | Other current assets | $ | $ | ||||||||||||||||||||||||||||||||
Total other financial instruments | $ | $ |
June 30, 2024 | |||||||||||||||||||||||
Foreign Currency Contracts | Foreign Currency Debt | Commodity Contracts | Total | ||||||||||||||||||||
Fair Value Hedges | $ | $ | $ | $ | |||||||||||||||||||
Cash Flow Hedges | |||||||||||||||||||||||
Net Investment Hedges |
December 31, 2023 | |||||||||||||||||||||||
Foreign Currency Contracts | Foreign Currency Debt | Commodity Contracts | Total | ||||||||||||||||||||
Fair Value Hedges | $ | $ | $ | $ | |||||||||||||||||||
Cash Flow Hedges | |||||||||||||||||||||||
Net Investment Hedges |
Gain (Loss) Recognized in Income | ||||||||||||||||||||||||||||||||
Location of Gain (Loss) Recognized in Income | Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||||||||
Hedging instruments: | ||||||||||||||||||||||||||||||||
Foreign currency contracts | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||||||
Total gain (loss) on fair value hedges | $ | ( | $ | $ | ( | $ |
Gain (Loss) Recognized in AOCI | Amount Reclassified from AOCI Into Income | |||||||||||||||||||||||||||||||
Three Months Ended June 30, | Location of Gain (Loss) Recognized in Income | Three Months Ended June 30, | ||||||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||||||||
Hedging instruments: | ||||||||||||||||||||||||||||||||
Foreign currency contracts | $ | $ | ( | Cost of Sales | $ | $ | ( | |||||||||||||||||||||||||
Commodity contracts | ( | ( | Cost of Sales | ( | ( | |||||||||||||||||||||||||||
Forward Starting Swaps | ( | ( | Interest (income) expense, net | |||||||||||||||||||||||||||||
Total gain (loss) on cash flow hedges | $ | ( | $ | ( | $ | ( | $ | ( |
Gain (Loss) Recognized in AOCI | Amount Reclassified from AOCI Into Income | |||||||||||||||||||||||||||||||
Six Months Ended June 30, | Location of Gain (Loss) Recognized in Income | Six Months Ended June 30, | ||||||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||||||||
Hedging instruments: | ||||||||||||||||||||||||||||||||
Foreign currency contracts | $ | $ | ( | Cost of Sales | $ | ( | $ | |||||||||||||||||||||||||
Commodity contracts | ( | ( | Cost of Sales | ( | ||||||||||||||||||||||||||||
Forward Starting Swaps | ( | Interest (income) expense, net | ||||||||||||||||||||||||||||||
Total gain (loss) on cash flow hedges | $ | ( | $ | $ | ( | $ |
Gain (Loss) Recognized in AOCI | ||||||||||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||
Hedging instruments: | ||||||||||||||||||||||||||
Foreign currency contracts | $ | $ | $ | $ | ||||||||||||||||||||||
Foreign currency debt | ||||||||||||||||||||||||||
Total gain (loss) on net investment hedges | $ | $ | $ | $ |
Three Months Ended June 30, | ||||||||||||||
2024 | 2023 | |||||||||||||
Gross profit, GAAP | $ | 3,066 | $ | 2,787 | ||||||||||
2022 Global Productivity Initiative | 9 | — | ||||||||||||
Gross profit, non-GAAP | $ | 3,075 | $ | 2,787 |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Basis Point Change | ||||||||||||||||||
Gross profit margin, GAAP | 60.6 | % | 57.8 | % | 280 | |||||||||||||||
2022 Global Productivity Initiative | 0.2 | % | — | |||||||||||||||||
Gross profit margin, non-GAAP | 60.8 | % | 57.8 | % | 300 |
Three Months Ended June 30, | ||||||||||||||
2024 | 2023 | |||||||||||||
Selling, general and administrative expenses, GAAP | $ | 1,939 | $ | 1,768 | ||||||||||
2022 Global Productivity Initiative | (2) | (2) | ||||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,937 | $ | 1,766 |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Basis Point Change | ||||||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 38.3 | % | 36.7 | % | 160 | |||||||||||||||
2022 Global Productivity Initiative | — | (0.1) | ||||||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 38.3 | % | 36.6 | % | 170 |
Three Months Ended June 30, | ||||||||||||||
2024 | 2023 | |||||||||||||
Other (income) expense, net, GAAP | $ | 35 | $ | 45 | ||||||||||
2022 Global Productivity Initiative | (16) | (16) | ||||||||||||
Other (income) expense, net, non-GAAP | $ | 20 | $ | 29 |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | % Change | ||||||||||||||||||
Operating profit, GAAP | $ | 1,092 | $ | 974 | 12 | % | ||||||||||||||
2022 Global Productivity Initiative | 27 | 18 | ||||||||||||||||||
Operating profit, non-GAAP | $ | 1,118 | $ | 992 | 13 | % |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Basis Point Change | ||||||||||||||||||
Operating profit margin, GAAP | 21.6 | % | 20.2 | % | 140 | |||||||||||||||
2022 Global Productivity Initiative | 0.5 | % | 0.4 | % | ||||||||||||||||
Operating profit margin, non-GAAP | 22.1 | % | 20.6 | % | 150 |
Three Months Ended June 30, | ||||||||||||||
2024 | 2023 | |||||||||||||
Non-service related postretirement costs, GAAP | $ | 22 | $ | 29 | ||||||||||
2022 Global Productivity Initiative | — | (3) | ||||||||||||
Non-service related postretirement costs, non-GAAP | $ | 22 | $ | 26 |
Three Months Ended June 30, 2024 | |||||||||||||||||||||||||||||||||||
Income Before Income Taxes | Provision For Income Taxes(1) | Net Income Including Noncontrolling Interests | Less: Income Attributable to Noncontrolling Interests | Net Income Attributable To Colgate-Palmolive Company | Diluted Earnings Per Share(2) | ||||||||||||||||||||||||||||||
As Reported GAAP | $ | 1,010 | $ | 243 | $ | 767 | $ | 36 | $ | 731 | $ | 0.89 | |||||||||||||||||||||||
2022 Global Productivity Initiative | 27 | 4 | 23 | — | 23 | 0.02 | |||||||||||||||||||||||||||||
Non-GAAP | $ | 1,036 | $ | 247 | $ | 789 | $ | 36 | $ | 753 | $ | 0.91 |
Three Months Ended June 30, 2023 | |||||||||||||||||||||||||||||||||||
Income Before Income Taxes | Provision For Income Taxes(1) | Net Income Including Noncontrolling Interests | Less: Income Attributable to Noncontrolling Interests | Net Income Attributable To Colgate-Palmolive Company | Diluted Earnings Per Share(2) | ||||||||||||||||||||||||||||||
As Reported GAAP | $ | 887 | $ | 353 | $ | 534 | $ | 32 | $ | 502 | $ | 0.60 | |||||||||||||||||||||||
Foreign tax matter | — | (126) | 126 | — | 126 | 0.15 | |||||||||||||||||||||||||||||
2022 Global Productivity Initiative | 21 | 4 | 17 | 1 | 16 | 0.02 | |||||||||||||||||||||||||||||
Non-GAAP | $ | 908 | $ | 231 | $ | 677 | $ | 33 | $ | 644 | $ | 0.77 |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Change | ||||||||||||||||||
Net sales | $ | 1,002 | $ | 978 | 2.5 | % | ||||||||||||||
Operating profit | $ | 223 | $ | 227 | (2) | % | ||||||||||||||
% of Net sales | 22.3 | % | 23.2 | % | (90) | bps |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Change | ||||||||||||||||||
Net sales | $ | 1,267 | $ | 1,178 | 7.6 | % | ||||||||||||||
Operating profit | $ | 417 | $ | 363 | 15 | % | ||||||||||||||
% of Net sales | 32.9 | % | 30.8 | % | 210 | bps |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Change | ||||||||||||||||||
Net sales | $ | 720 | $ | 678 | 6.2 | % | ||||||||||||||
Operating profit | $ | 159 | $ | 134 | 19 | % | ||||||||||||||
% of Net sales | 22.1 | % | 19.8 | % | 230 | bps |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Change | ||||||||||||||||||
Net sales | $ | 682 | $ | 664 | 2.6 | % | ||||||||||||||
Operating profit | $ | 195 | $ | 169 | 16 | % | ||||||||||||||
% of Net sales | 28.7 | % | 25.5 | % | 320 | bps |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Change | ||||||||||||||||||
Net sales | $ | 273 | $ | 268 | 2.2 | % | ||||||||||||||
Operating profit | $ | 64 | $ | 62 | 4 | % | ||||||||||||||
% of Net sales | 23.4 | % | 23.1 | % | 30 | bps |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Change | ||||||||||||||||||
Net sales | $ | 1,114 | $ | 1,056 | 5.5 | % | ||||||||||||||
Operating profit | $ | 235 | $ | 191 | 23 | % | ||||||||||||||
% of Net sales | 21.1 | % | 18.1 | % | 300 | bps |
Three Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Change | ||||||||||||||||||
Operating profit (loss) | $ | (201) | $ | (172) | 17 | % |
Six Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
Net sales | |||||||||||
Oral, Personal and Home Care | |||||||||||
North America | $ | 1,999 | $ | 1,936 | |||||||
Latin America | 2,520 | 2,253 | |||||||||
Europe | 1,432 | 1,328 | |||||||||
Asia Pacific | 1,408 | 1,402 | |||||||||
Africa/Eurasia | 549 | 556 | |||||||||
Total Oral, Personal and Home Care | 7,908 | 7,475 | |||||||||
Pet Nutrition | 2,216 | 2,117 | |||||||||
Total Net sales | $ | 10,124 | $ | 9,592 | |||||||
Operating profit | |||||||||||
Oral, Personal and Home Care | |||||||||||
North America | $ | 445 | $ | 420 | |||||||
Latin America | 822 | 678 | |||||||||
Europe | 303 | 250 | |||||||||
Asia Pacific | 402 | 371 | |||||||||
Africa/Eurasia | 130 | 130 | |||||||||
Total Oral, Personal and Home Care | 2,102 | 1,849 | |||||||||
Pet Nutrition | 433 | 374 | |||||||||
Corporate | (397) | (340) | |||||||||
Total Operating profit | $ | 2,139 | $ | 1,883 |
For the Six Months Ended June 30, 2024 vs. 2023 | ||||||||||||||||||||||||||||||||
Oral, Personal and Home Care | Net Sales | Organic Sales | As Reported Volume | Pricing | Foreign Exchange | |||||||||||||||||||||||||||
North America | 3.2% | 3.3% | 4.4% | (1.1)% | —% | |||||||||||||||||||||||||||
Latin America | 11.8% | 22.2% | 5.8% | 16.4% | (10.4)% | |||||||||||||||||||||||||||
Europe | 7.8% | 6.8% | 4.2% | 2.7% | 1.0% | |||||||||||||||||||||||||||
Asia Pacific | 0.4% | 3.2% | 0.1% | 3.1% | (2.7)% | |||||||||||||||||||||||||||
Africa/Eurasia | (1.3)% | 16.3% | 6.1% | 10.2% | (17.6)% | |||||||||||||||||||||||||||
Total Oral, Personal and Home Care | 5.8% | 10.6% | 4.1% | 6.5% | (4.8)% | |||||||||||||||||||||||||||
Pet Nutrition | 4.7% | 5.2% | (0.7)% | 5.9% | (0.5)% | |||||||||||||||||||||||||||
Total Company | 5.5% | 9.4% | 3.0% | 6.3% | (3.8)% | |||||||||||||||||||||||||||
Six Months Ended June 30, | ||||||||||||||
2024 | 2023 | |||||||||||||
Gross profit, GAAP | $ | 6,105 | $ | 5,499 | ||||||||||
2022 Global Productivity Initiative | 9 | — | ||||||||||||
Gross profit, non-GAAP | $ | 6,114 | $ | 5,499 |
Six Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Basis Point Change | ||||||||||||||||||
Gross profit margin, GAAP | 60.3 | % | 57.3 | % | 300 | |||||||||||||||
2022 Global Productivity Initiative | 0.1 | % | — | % | ||||||||||||||||
Gross profit margin, non-GAAP | 60.4 | % | 57.3 | % | 310 | |||||||||||||||
Six Months Ended June 30, | ||||||||||||||
2024 | 2023 | |||||||||||||
Selling, general and administrative expenses, GAAP | $ | 3,855 | $ | 3,526 | ||||||||||
2022 Global Productivity Initiative | (3) | (2) | ||||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 3,852 | $ | 3,524 | ||||||||||
Six Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Basis Point Change | ||||||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 38.1 | % | 36.8 | % | 130 | |||||||||||||||
2022 Global Productivity Initiative | (0.1) | (0.1) | ||||||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 38.0 | % | 36.7 | % | 130 |
Six Months Ended June 30, | ||||||||||||||
2024 | 2023 | |||||||||||||
Other (income) expense, net, GAAP | $ | 111 | $ | 90 | ||||||||||
2022 Global Productivity Initiative | (51) | (21) | ||||||||||||
Product recall costs | — | (25) | ||||||||||||
Other (income) expense, net, non-GAAP | $ | 60 | $ | 44 |
Six Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | % Change | ||||||||||||||||||
Operating profit, GAAP | $ | 2,139 | $ | 1,883 | 14 | % | ||||||||||||||
2022 Global Productivity Initiative | 63 | 23 | ||||||||||||||||||
Product recall costs | — | 25 | ||||||||||||||||||
Operating profit, non-GAAP | $ | 2,202 | $ | 1,931 | 14 | % |
Six Months Ended June 30, | ||||||||||||||||||||
2024 | 2023 | Basis Point Change | ||||||||||||||||||
Operating profit margin, GAAP | 21.1 | % | 19.6 | % | 150 | |||||||||||||||
2022 Global Productivity Initiative | 0.7 | 0.2 | ||||||||||||||||||
Product recall costs | — | 0.3 | ||||||||||||||||||
Operating profit margin, non-GAAP | 21.8 | % | 20.1 | % | 170 |
Six Months Ended June 30, | ||||||||||||||
2024 | 2023 | |||||||||||||
Non-service related postretirement costs, GAAP | $ | 44 | $ | 323 | ||||||||||
2022 Global Productivity Initiative | — | (4) | ||||||||||||
ERISA litigation matter | — | (267) | ||||||||||||
Non-service related postretirement costs, non-GAAP | $ | 44 | $ | 52 |
Three Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||||||||||||||
Income Before Income Taxes | Provision For Income Taxes(1) | Effective Income Tax Rate(2) | Income Before Income Taxes | Provision For Income Taxes(1) | Effective Income Tax Rate(2) | |||||||||||||||||||||||||||||||||
As Reported GAAP | $ | 1,010 | $ | 243 | 24.1 | % | $ | 887 | $ | 353 | 39.8 | % | ||||||||||||||||||||||||||
2022 Global Productivity Initiative | 27 | 4 | (0.3) | 21 | 4 | (0.2) | ||||||||||||||||||||||||||||||||
Foreign tax matter | — | — | — | — | (126) | (14.2) | ||||||||||||||||||||||||||||||||
Non-GAAP | $ | 1,036 | $ | 247 | 23.8 | % | $ | 908 | $ | 231 | 25.4 | % |
Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||||||||||||||
Income Before Income Taxes | Provision For Income Taxes(1) | Effective Income Tax Rate(2) | Income Before Income Taxes | Provision For Income Taxes(1) | Effective Income Tax Rate(2) | |||||||||||||||||||||||||||||||||
As Reported GAAP | $ | 1,977 | $ | 482 | 24.4 | % | $ | 1,448 | $ | 500 | 34.5 | % | ||||||||||||||||||||||||||
2022 Global Productivity Initiative | 63 | 10 | (0.3) | 27 | 5 | (0.1) | ||||||||||||||||||||||||||||||||
ERISA litigation matter | — | — | — | 267 | 55 | (2.2) | ||||||||||||||||||||||||||||||||
Foreign tax matter | — | — | — | — | (126) | (7.3) | ||||||||||||||||||||||||||||||||
Product recall costs | — | — | — | 25 | 6 | — | ||||||||||||||||||||||||||||||||
Non-GAAP | $ | 2,040 | $ | 492 | 24.1 | % | $ | 1,767 | $ | 440 | 24.9 | % |
Six Months Ended June 30, 2024 | |||||||||||||||||||||||||||||||||||
Income Before Income Taxes | Provision For Income Taxes(1) | Net Income Including Noncontrolling Interests | Less: Income Attributable to Noncontrolling Interests | Net Income Attributable To Colgate-Palmolive Company | Diluted Earnings Per Share(2) | ||||||||||||||||||||||||||||||
As Reported GAAP | $ | 1,977 | $ | 482 | $ | 1,495 | $ | 81 | $ | 1,414 | $ | 1.71 | |||||||||||||||||||||||
2022 Global Productivity Initiative | 63 | 10 | 53 | — | 53 | 0.07 | |||||||||||||||||||||||||||||
Non-GAAP | $ | 2,040 | $ | 492 | $ | 1,548 | $ | 81 | $ | 1,467 | $ | 1.78 |
Six Months Ended June 30, 2023 | |||||||||||||||||||||||||||||||||||
Income Before Income Taxes | Provision For Income Taxes(1) | Net Income Including Noncontrolling Interests | Less: Income Attributable to Noncontrolling Interests | Net Income Attributable To Colgate-Palmolive Company | Diluted Earnings Per Share(2) | ||||||||||||||||||||||||||||||
As Reported GAAP | $ | 1,448 | $ | 500 | $ | 948 | $ | 74 | $ | 874 | $ | 1.05 | |||||||||||||||||||||||
ERISA litigation matter | 267 | 55 | 212 | — | 212 | 0.25 | |||||||||||||||||||||||||||||
Foreign tax matter | — | (126) | 126 | — | 126 | 0.15 | |||||||||||||||||||||||||||||
2022 Global Productivity Initiative | 27 | 5 | 22 | 1 | 21 | 0.03 | |||||||||||||||||||||||||||||
Product recall costs | 25 | 6 | 19 | — | 19 | 0.02 | |||||||||||||||||||||||||||||
Non-GAAP | $ | 1,767 | $ | 440 | $ | 1,327 | $ | 75 | $ | 1,252 | $ | 1.50 |
Six Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
Gross Profit | $ | 9 | $ | — | |||||||
Selling, general and administrative expenses | 3 | 2 | |||||||||
Other (income) expense, net | 51 | 21 | |||||||||
Non-service related postretirement costs | — | 4 | |||||||||
Total 2022 Global Productivity Initiative charges, pretax | $ | 63 | $ | 27 | |||||||
Total 2022 Global Productivity Initiative charges, aftertax | $ | 53 | $ | 21 |
Six Months Ended June 30, | Program-to-date Accumulated Charges | ||||||||||||||||
2024 | 2023 | ||||||||||||||||
North America | — | % | 14 | % | 8 | % | |||||||||||
Latin America | — | % | 2 | % | 9 | % | |||||||||||
Europe | 90 | % | 26 | % | 41 | % | |||||||||||
Asia Pacific | — | % | 22 | % | 8 | % | |||||||||||
Africa/Eurasia | 1 | % | 2 | % | 7 | % | |||||||||||
Hill’s Pet Nutrition | 8 | % | 15 | % | 12 | % | |||||||||||
Corporate | 1 | % | 19 | % | 15 | % | |||||||||||
Total | 100 | % | 100 | % | 100 | % |
Cumulative Charges | ||||||||
as of June 30, 2024 | ||||||||
Employee-Related Costs | $ | 175 | ||||||
Incremental Depreciation | 7 | |||||||
Asset Impairments | 1 | |||||||
Other | 22 | |||||||
Total | $ | 205 |
Six Months Ended June 30, 2024 | ||||||||||||||||||||||||||||||||
Employee-Related Costs | Incremental Depreciation | Asset Impairments | Other | Total | ||||||||||||||||||||||||||||
Balance at December 31, 2023 | $ | 10 | $ | — | $ | — | $ | 1 | $ | 11 | ||||||||||||||||||||||
Charges | 49 | 7 | — | 7 | 63 | |||||||||||||||||||||||||||
Cash Payments | (10) | — | — | (5) | (15) | |||||||||||||||||||||||||||
Charges against assets | — | (7) | — | — | (7) | |||||||||||||||||||||||||||
Foreign exchange | (1) | — | — | — | (1) | |||||||||||||||||||||||||||
Balance at June 30, 2024 | $ | 48 | $ | — | $ | — | $ | 3 | $ | 51 | ||||||||||||||||||||||
Three Months Ended June 30, 2024 | Net Sales Growth (GAAP) | Foreign Exchange Impact | Acquisitions and Divestments Impact | Organic Sales Growth (Non-GAAP) | ||||||||||
Oral, Personal and Home Care | ||||||||||||||
North America | 2.5% | (0.1)% | —% | 2.5% | ||||||||||
Latin America | 7.6% | (11.2)% | —% | 18.8% | ||||||||||
Europe | 6.2% | (0.2)% | —% | 6.5% | ||||||||||
Asia Pacific | 2.6% | (2.5)% | —% | 5.1% | ||||||||||
Africa/Eurasia | 2.2% | (14.3)% | —% | 16.4% | ||||||||||
Total Oral, Personal and Home Care | 4.7% | (5.0)% | —% | 9.8% | ||||||||||
Pet Nutrition | 5.5% | (0.7)% | —% | 6.1% | ||||||||||
Total Company | 4.9% | (4.1)% | —% | 9.0% |
Six Months Ended June 30, 2024 | Net Sales Growth (GAAP) | Foreign Exchange Impact | Acquisitions and Divestments Impact | Organic Sales Growth (Non-GAAP) | ||||||||||
Oral, Personal and Home Care | ||||||||||||||
North America | 3.2% | —% | —% | 3.3% | ||||||||||
Latin America | 11.8% | (10.4)% | —% | 22.2% | ||||||||||
Europe | 7.8% | 1.0% | —% | 6.8% | ||||||||||
Asia Pacific | 0.4% | (2.7)% | —% | 3.2% | ||||||||||
Africa/Eurasia | (1.3)% | (17.6)% | —% | 16.3% | ||||||||||
Total Oral, Personal and Home Care | 5.8% | (4.8)% | —% | 10.6% | ||||||||||
Pet Nutrition | 4.7% | (0.5)% | —% | 5.2% | ||||||||||
Total Company | 5.5% | (3.8)% | —% | 9.4% |
Month | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2) | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(3) (in millions) | ||||||||||||||||||||||
April 1 through 30, 2024 | 1,014,319 | $ | 87.80 | 1,014,319 | $ | 2,265 | ||||||||||||||||||||
May 1 through 31, 2024 | 1,731,098 | $ | 93.23 | 1,725,858 | $ | 2,104 | ||||||||||||||||||||
June 1 through 30, 2024 | 2,081,617 | $ | 95.98 | 2,080,600 | $ | 1,904 | ||||||||||||||||||||
Total | 4,827,034 | $ | 93.27 | 4,820,777 |
Exhibit No. | Description | |||||||
31-A | ||||||||
31-B | ||||||||
32 | ||||||||
101 | The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2024, formatted in Inline eXtensible Business Reporting Language (Inline XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; (v) Condensed Consolidated Statements of Changes in Shareholders’ Equity; and (vi) Notes to Condensed Consolidated Financial Statements. | |||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
COLGATE-PALMOLIVE COMPANY | |||||
(Registrant) | |||||
Principal Executive Officer: | |||||
July 26, 2024 | /s/ Noel R. Wallace | ||||
Noel R. Wallace | |||||
Chairman of the Board, President and Chief Executive Officer | |||||
Principal Financial Officer: | |||||
July 26, 2024 | /s/ Stanley J. Sutula III | ||||
Stanley J. Sutula III | |||||
Chief Financial Officer | |||||
Principal Accounting Officer: | |||||
July 26, 2024 | /s/ Gregory O. Malcolm | ||||
Gregory O. Malcolm | |||||
Executive Vice President and Controller |
/s/ Noel R. Wallace | ||
Noel R. Wallace | ||
Chairman of the Board, President and Chief Executive Officer |
/s/ Stanley J. Sutula III | ||
Stanley J. Sutula III | ||
Chief Financial Officer |
/s/ Noel R. Wallace | ||
Noel R. Wallace | ||
Chairman of the Board, President and | ||
Chief Executive Officer | ||
/s/ Stanley J. Sutula III | ||
Stanley J. Sutula III | ||
Chief Financial Officer |
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Statement of Comprehensive Income [Abstract] | ||||
Net income including noncontrolling interests | $ 767 | $ 534 | $ 1,495 | $ 948 |
Other comprehensive income (loss), net of tax: | ||||
Cumulative translation adjustments | (118) | 27 | (212) | 70 |
Retirement plans and other retiree benefit adjustments | 6 | 6 | 11 | 13 |
Gains (losses) on cash flow hedges | 2 | (10) | 2 | (4) |
Total Other comprehensive income (loss), net of tax | (110) | 23 | (199) | 79 |
Total Comprehensive income including noncontrolling interests | 657 | 557 | 1,296 | 1,027 |
Less: Net income attributable to noncontrolling interests | 36 | 32 | 81 | 74 |
Less: Cumulative translation adjustments attributable to noncontrolling interests | (1) | (25) | (8) | (41) |
Total Comprehensive income attributable to noncontrolling interests | 35 | 7 | 73 | 33 |
Total Comprehensive income attributable to Colgate-Palmolive Company | $ 622 | $ 550 | $ 1,223 | $ 994 |
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions |
Jun. 30, 2024 |
Dec. 31, 2023 |
---|---|---|
Current Assets | ||
Allowance for doubtful accounts receivable, current | $ 84 | $ 80 |
Shareholders’ Equity | ||
Common stock par value (in dollars per share) | $ 1 | $ 1 |
Common stock authorized (in shares) | 2,000,000,000 | 2,000,000,000 |
Common stock issued (in shares) | 1,465,706,360 | 1,465,706,360 |
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($) $ in Millions |
Total |
Common Stock |
Additional Paid-in Capital |
Unearned Compensation |
Treasury Stock |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Noncontrolling Interests |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance at Dec. 31, 2022 | $ 1,466 | $ 3,546 | $ (1) | $ (25,128) | $ 24,573 | $ (4,055) | [1] | $ 405 | |||||||
Changes in Shareholders' Equity [Roll Forward] | |||||||||||||||
Net income | $ 948 | 874 | 74 | ||||||||||||
Other comprehensive income (loss), net of tax | 79 | 120 | [1] | (41) | |||||||||||
Dividends | [2] | (1,189) | (59) | ||||||||||||
Stock-based compensation expense | 37 | ||||||||||||||
Shares issued for stock options | 116 | 127 | |||||||||||||
Shares issued for restricted stock units | (14) | 14 | |||||||||||||
Treasury stock acquired | (551) | ||||||||||||||
Other | 3 | 1 | (3) | ||||||||||||
Ending balance at Jun. 30, 2023 | 1,466 | 3,688 | 0 | (25,541) | 24,258 | (3,935) | [1],[3] | 379 | |||||||
Beginning balance at Mar. 31, 2023 | 1,466 | 3,603 | 0 | (25,245) | 24,153 | (3,983) | [3] | 431 | |||||||
Changes in Shareholders' Equity [Roll Forward] | |||||||||||||||
Net income | 534 | 502 | 32 | ||||||||||||
Other comprehensive income (loss), net of tax | 23 | 48 | [3] | (25) | |||||||||||
Dividends | (59) | (397) | |||||||||||||
Stock-based compensation expense | 23 | ||||||||||||||
Shares issued for stock options | 62 | 77 | |||||||||||||
Shares issued for restricted stock units | (1) | 1 | |||||||||||||
Treasury stock acquired | (371) | ||||||||||||||
Other | 1 | (3) | |||||||||||||
Ending balance at Jun. 30, 2023 | 1,466 | 3,688 | 0 | (25,541) | 24,258 | (3,935) | [1],[3] | 379 | |||||||
Beginning balance at Dec. 31, 2023 | 957 | 1,466 | 3,808 | 0 | (26,017) | 25,289 | (3,937) | 348 | |||||||
Changes in Shareholders' Equity [Roll Forward] | |||||||||||||||
Net income | 1,495 | 1,414 | 81 | ||||||||||||
Other comprehensive income (loss), net of tax | (199) | (191) | (8) | ||||||||||||
Dividends | (1,217) | (63) | |||||||||||||
Stock-based compensation expense | 43 | ||||||||||||||
Shares issued for stock options | 202 | 250 | |||||||||||||
Shares issued for restricted stock units | (22) | 22 | |||||||||||||
Treasury stock acquired | (989) | ||||||||||||||
Other | 4 | (2) | 1 | ||||||||||||
Ending balance at Jun. 30, 2024 | 482 | 1,466 | 4,035 | 0 | (26,736) | 25,486 | (4,128) | [3] | 359 | ||||||
Beginning balance at Mar. 31, 2024 | 1,466 | 3,962 | 0 | (26,343) | 25,164 | (4,019) | [3] | 387 | |||||||
Changes in Shareholders' Equity [Roll Forward] | |||||||||||||||
Net income | 767 | 731 | 36 | ||||||||||||
Other comprehensive income (loss), net of tax | (110) | (109) | [3] | (1) | |||||||||||
Dividends | (409) | (63) | |||||||||||||
Stock-based compensation expense | 24 | ||||||||||||||
Shares issued for stock options | 48 | 87 | |||||||||||||
Shares issued for restricted stock units | (1) | 1 | |||||||||||||
Treasury stock acquired | (480) | ||||||||||||||
Other | 2 | (1) | |||||||||||||
Ending balance at Jun. 30, 2024 | $ 482 | $ 1,466 | $ 4,035 | $ 0 | $ (26,736) | $ 25,486 | $ (4,128) | [3] | $ 359 | ||||||
|
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Parenthetical) $ in Millions |
3 Months Ended | 6 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2024
USD ($)
$ / shares
|
Mar. 31, 2024
USD ($)
dividend
|
Jun. 30, 2023
USD ($)
$ / shares
|
Mar. 31, 2023
USD ($)
dividend
|
Jun. 30, 2024
USD ($)
$ / shares
|
Jun. 30, 2023
USD ($)
$ / shares
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
|
Statement of Stockholders' Equity [Abstract] | ||||||||
Dividends declared per common share (in dollars per share) | $ / shares | $ 0.50 | $ 0.48 | $ 1.48 | $ 1.43 | ||||
Accumulated other comprehensive loss, cumulative translation losses | $ 3,555 | $ 3,438 | $ 3,381 | $ 3,431 | $ 3,555 | $ 3,381 | $ 3,351 | $ 3,491 |
Accumulated other comprehensive income (loss), unrecognized retirement plan and other retiree benefit costs | $ 636 | $ 643 | $ 618 | $ 624 | $ 636 | $ 618 | $ 647 | $ 631 |
Number of dividends declared per quarter | dividend | 2 | 2 |
Basis of Presentation |
6 Months Ended |
---|---|
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Note that certain columns and rows may not sum due to rounding. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation. For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”).
|
Use of Estimates |
6 Months Ended |
---|---|
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.
|
Recent Accounting Pronouncements and Disclosure Rules |
6 Months Ended |
---|---|
Jun. 30, 2024 | |
Accounting Standards Update and Change in Accounting Principle [Abstract] | |
Recent Accounting Pronouncements and Disclosure Rules | Recent Accounting Pronouncements and Disclosure Rules In March 2024, the SEC finalized rules intended to enhance and standardize climate-related disclosures in registrants’ registration statements and Annual Reports on Form 10-K. The new rules would require climate-related disclosures, including as they relate to governance, strategy, risk management, targets and goals and greenhouse gas emissions. In addition, the rules would require certain climate-related disclosures as it relates to severe weather events and other natural conditions and carbon offsets and renewable energy credits. In April 2024, the SEC voluntarily stayed the rules due to pending judicial review. As these rules only impact disclosures, they will not have a material impact on the Company’s Consolidated Financial Statements. In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the rate reconciliation, and income taxes paid disaggregated by jurisdiction. This guidance is effective for the Company for fiscal years beginning after December 15, 2024. As this accounting standard only impacts disclosures, it will not have a material impact on the Company’s Consolidated Financial Statements. In December 2023, the FASB issued ASU No. 2023-08, “Intangibles-Goodwill and Other-Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets.” This ASU improves the accounting for certain crypto assets by requiring companies to measure them at fair value for each reporting period with changes in fair value recognized in net income. This guidance is effective for the Company for fiscal years beginning after December 15, 2024 and is not expected to have an impact on the Company’s Consolidated Financial Statements. In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU modified the disclosure and presentation requirements primarily through enhanced disclosures of significant segment expenses and other segment items. This guidance is effective for the Company for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. As this accounting standard only impacts disclosures, it will not have a material impact on the Company’s Consolidated Financial Statements. In October 2023, the FASB issued ASU No. 2023-06, “Disclosure Improvements-Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC’s regulations. This guidance is effective for the Company no later than June 30, 2027 and is not expected to have a material impact on the Company’s Consolidated Financial Statements. In August 2023, the FASB issued ASU No. 2023-05, “Business Combinations-Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement.” This ASU requires a joint venture to initially measure all contributions received upon its formation at fair value. This guidance is applicable to joint ventures with a formation date on or after January 1, 2025 and is not expected to have a material impact on the Company’s Consolidated Financial Statements. In March 2023, the FASB issued ASU No. 2023-01, “Leases (Topic 842): Common Control Arrangements.” This ASU clarified the accounting for leasehold improvements for leases under common control. The guidance was effective for the Company beginning on January 1, 2024 and did not have a material impact on the Company’s Consolidated Financial Statements. In September 2022, the FASB issued ASU No. 2022-04, “Liabilities-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires a buyer that uses supplier finance programs to make annual disclosures about the programs’ key terms, the balance sheet presentation of related amounts, the confirmed amount outstanding at the end of the period and associated roll-forward information. The Company adopted the guidance beginning on January 1, 2023, and with respect to the roll-forward information disclosure, beginning on January 1, 2024. See Note 12, Supplier Finance Program for additional information.
|
Restructuring and Related Implementation Charges |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Implementation Charges | Restructuring and Related Implementation Charges On January 27, 2022, the Company’s Board of Directors (the “Board”) approved a targeted productivity program (the “2022 Global Productivity Initiative”). Substantially all initiatives under the program have been implemented as of the second quarter of 2024 and the Company expects to incur the remaining charges in the second half of 2024. The 2022 Global Productivity Initiative resulted in the reallocation of resources towards the Company’s strategic priorities and faster growth businesses, efficiencies in the Company’s operations and the streamlining of its supply chain to reduce structural costs. Total pretax charges from the implementation of the 2022 Global Productivity Initiative are now expected to be approximately $225 ($180 aftertax), once all the charges are recorded, which is now estimated to be comprised of the following categories: employee-related costs, including severance, pension and other termination benefits (80%); asset-related costs, primarily accelerated depreciation and asset write-downs (5%); and other charges (15%), which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities and the implementation of new strategies. It is now estimated that approximately 80% of the charges will result in cash expenditures. It is now expected that the cumulative pretax charges, once all charges are recorded, will relate to initiatives undertaken in North America (10%), Latin America (10%), Europe (45%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (15%). For the three months ended June 30, 2024, charges resulting from the 2022 Global Productivity Initiative were $27 pretax ($23 aftertax). For the three months ended June 30, 2023, charges resulting from the 2022 Global Productivity Initiative were $21 pretax ($16 aftertax). For the six months ended June 30, 2024 and June 30, 2023, charges resulting from the 2022 Global Productivity Initiative are reflected in the income statement as follows:
Restructuring and related implementation charges were recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges incurred for the 2022 Global Productivity Initiative relate to initiatives undertaken by the following reportable operating segments and Corporate:
Since the inception of the 2022 Global Productivity Initiative, the Company has incurred cumulative pretax charges of $205 ($165 aftertax) in connection with the implementation of various projects as follows:
The following table summarizes the activity for the restructuring and related implementation charges discussed above and the related accruals:
Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, written severance policies, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension enhancements which are reflected as Charges against assets within Employee-Related Costs in the preceding table as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension liabilities. For the six months ended June 30, 2024, there were no pension enhancements included in Charges against assets within Employee-Related Costs. Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.
|
Inventories |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory, Net, Items Net of Reserve Alternative [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories | Inventories Inventories by major class were as follows:
|
Earnings Per Share |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | Earnings Per Share For the three months ended June 30, 2024 and 2023, earnings per share were as follows:
For the three months ended June 30, 2024 and 2023, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 14,865 and 6,268,944, respectively. For the six months ended June 30, 2024 and 2023, earnings per share were as follows:
For the six months ended June 30, 2024 and 2023, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 23,044 and 13,482,312, respectively. Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in the number of shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.
|
Other Comprehensive Income (Loss) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Comprehensive Income (Loss) | Other Comprehensive Income (Loss) Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three and six months ended June 30, 2024 and 2023 were as follows:
(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details. (2) These (gains) losses are reclassified into Cost of sales. See Note 11, Fair Value Measurements and Financial Instruments for additional details. There were no tax impacts on Other comprehensive income (loss) (“OCI”) attributable to Noncontrolling interests.
|
Retirement Plans and Other Retiree Benefits |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Plans and Other Retiree Benefits | Retirement Plans and Other Retiree Benefits Components of Net periodic benefit cost for the three and six months ended June 30, 2024 and 2023 were as follows:
There were no other postretirement charges for the three and six months ended June 30, 2024. Other postretirement charges for the three and six months ended June 30, 2023 included pension and other charges of $3 and $4, respectively, incurred pursuant to the 2022 Global Productivity Initiative. In the first quarter of 2023, the Company recorded a charge of $267 as a result of a decision of the United States Court of Appeals for the Second Circuit (the “Second Circuit”) affirming a grant of summary judgment to the plaintiffs in a lawsuit under the Employee Retirement Income Security Act (“ERISA”) seeking the recalculation of benefits and other relief associated with a 2005 residual annuity amendment to the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Retirement Plan”). The decision resulted in an increase in the obligations of the Retirement Plan, which based on the current funded status of the Retirement Plan will require no immediate cash contribution by the Company. See Note 9, Contingencies for additional information. For the three and six months ended June 30, 2024 and 2023, the Company made no voluntary contributions to its U.S. postretirement plans.
|
Contingencies |
6 Months Ended |
---|---|
Jun. 30, 2024 | |
Loss Contingency [Abstract] | |
Contingencies | Contingencies As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites. The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances. The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $275 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate range may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year. Brazilian Matters There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”). The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $117. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. In each of September 2015, February 2017, September 2018, April 2019 and August 2020, the Company lost an administrative appeal and subsequently challenged these assessments in the Brazilian federal courts. Currently, there are three lawsuits pending in the Lower Federal Court and two cases have progressed to the Federal Court of Appeals. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously. In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously. In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $52, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously. Competition Matter Certain of the Company’s subsidiaries were historically subject to actions and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status as of June 30, 2024 of such competition law matters pending against the Company during the six months ended June 30, 2024 is set forth below. ▪In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company appealed the decision to the Greek courts. In April 2019, the Greek courts affirmed the judgment against the Company’s Greek subsidiary, but reduced the fine to $10.5 and dismissed the case against Colgate-Palmolive Company. The Company’s Greek subsidiary and the Greek competition authority appealed the decision to the Greek Supreme Court. Talcum Powder Matters The Company has been named as a defendant in civil actions alleging that certain of its talcum powder products were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of June 30, 2024, there were 293 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 285 cases as of March 31, 2024 and 279 cases as of December 31, 2023. During the three months ended June 30, 2024, 40 new cases were filed and 32 cases were resolved by voluntary dismissal or settlement. During the six months ended June 30, 2024, 66 new cases were filed and 52 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in the periods presented was not material, either individually or in the aggregate, to such periods’ results of operations. During the three months ended March 31, 2024, one case resulted in a jury verdict in favor of the Company after a trial. During the three months ended June 30, 2024, the court entered a judgment granting plaintiffs’ motion for a new trial in that case. The Company is challenging that ruling. A significant portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes that a portion of the costs will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions, policy limits and insurance carrier insolvencies. While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. ERISA Matter In June 2016, a lawsuit was filed in the United States District Court for the Southern District of New York (the “District Court”) against the Retirement Plan, the Company and certain individuals (the “Company Defendants”) claiming that residual annuity payments associated with a 2005 residual annuity amendment to the Retirement Plan were improperly calculated for certain Retirement Plan participants in violation of ERISA. The relief sought included recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. This action was certified as a class action in July 2017. In July 2020, the District Court dismissed certain claims, and in August 2020 granted the plaintiffs’ motion for summary judgment on the remaining claims. In September 2020, the Company appealed to the Second Circuit. In March 2023, the Second Circuit affirmed the grant of summary judgment to the plaintiffs. In light of the Second Circuit decision, the Company recorded a charge to earnings of $267 in the quarter ended March 31, 2023, which is comprised of the recalculation of benefits and interest. Possible additional charges associated with this matter are expected to be immaterial and, where estimable, are reflected in the range of reasonably possible losses disclosed above. The decision resulted in an increase in the obligations of the Retirement Plan, which based on the current funded status of the Retirement Plan will require no immediate cash contribution by the Company. In June 2023, the Company filed a petition for certiorari to the United States Supreme Court requesting permission for an appeal to that court and that petition was denied in October 2023. Also, in June 2023, the plaintiffs filed a motion to enter a revised final judgment in the District Court to address certain unresolved calculation issues, which the Company opposed. In March 2024, the District Court granted the plaintiffs’ motion and found for the plaintiffs on those calculation issues. The Company is appealing that decision to the Second Circuit.
|
Segment Information |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | Segment Information The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. Net sales by segment were as follows:
Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
Operating profit by segment was as follows:
Note: Table may not sum due to rounding. Corporate Operating profit (loss) for the three months ended June 30, 2024 and June 30, 2023 included charges resulting from the 2022 Global Productivity Initiative of $27 and $18, respectively. Corporate Operating profit (loss) for the six months ended June 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $63. Corporate Operating profit (loss) for the six months ended June 30, 2023 included product recall costs of $25 and charges resulting from the 2022 Global Productivity Initiative of $23. In connection with management changes, the Company realigned the reporting structure of its skin health business effective July 1, 2024. Accordingly, commencing with the quarter ending September 30, 2024, the results of the skin health business previously reported within the Europe reportable operating segment will now be reported with our other skin health businesses in the North America reportable operating segment, with no impact on the Company's consolidated results of operations or financial position.
|
Fair Value Measurements and Financial Instruments |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements and Financial Instruments | Fair Value Measurements and Financial Instruments The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations. The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. The Company’s derivative instruments include forward-starting interest rate swaps, foreign currency contracts and commodity contracts. The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rate for future debt issuances and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months. The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Condensed Consolidated Balance Sheets at June 30, 2024 and December 31, 2023:
The carrying amount of cash, cash equivalents, marketable securities, accounts receivable and short-term debt approximated fair value as of June 30, 2024 and December 31, 2023. The estimated fair value of the Company’s long-term debt, including the current portion, as of June 30, 2024 and December 31, 2023, was $7,575 and $7,862, respectively, and the related carrying value was $8,167 and $8,239, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation). The following tables present the notional values as of:
The following table presents the location and amount of gain (loss) on fair value hedges recognized in the Company’s Condensed Consolidated Statements of Income:
The following tables present the amount of gain (loss) on cash flow hedges recognized in the Company’s Accumulated Other Comprehensive Income (AOCI) and reclassification from AOCI into the Condensed Consolidated Statements of Income:
The following table presents the amount of gain (loss) on net investment hedges recognized in the Company’s AOCI:
|
Supplier Finance Program |
6 Months Ended |
---|---|
Jun. 30, 2024 | |
Other Liabilities Disclosure [Abstract] | |
Supplier Finance Program | Supplier Finance Program The Company has agreements to provide supplier finance programs which facilitate participating suppliers’ ability to finance payment obligations of the Company with designated third-party financial institutions. Participating suppliers may, at their sole discretion, elect to finance one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under these arrangements. The outstanding payment obligations under the Company’s supplier finance programs are included in Accounts Payable in the Condensed Consolidated Balance Sheets and were not material as of June 30, 2024 or December 31, 2023.
|
Income Taxes |
6 Months Ended |
---|---|
Jun. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The effective income tax rate was 24.1% for the second quarter of 2024 as compared to 39.8% for the second quarter of 2023. The quarterly provision for income taxes is determined based on the Company’s estimated full year effective income tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 24.3%, as compared to 24.8% in the comparable period of 2023. In the third quarter of 2023, the Internal Revenue Service (the “IRS”) issued a notice giving taxpayers temporary relief from the effects of certain U.S. tax regulations that were issued in December 2021, which place greater restrictions on foreign taxes that are creditable against U.S. taxes on foreign-source income. This notice allowed taxpayers to defer the application of these new regulations through the end of 2023. In December 2023, the IRS issued further guidance modifying this temporary relief period to the date that a notice or other guidance withdrawing or modifying the temporary relief is issued. The Company will recognize the impact, if any, in the period in which the temporary relief is withdrawn or modified. The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013. One such matter relates to the IRS assessment of taxes on the Company by imputing income on certain activities within one of our international operations, which is also under audit for the years 2014 through 2018. There were U.S. Tax Court rulings during 2023 in favor of the IRS against unrelated third parties on similar matters. Despite the U.S. Tax Court rulings, the Company continues to believe that the tax assessment against the Company is without merit. While there can be no assurances, the Company believes this matter will ultimately be decided in favor of the Company. The amount of tax plus interest for the years 2010 through 2018 is estimated to be approximately $150, which is not included in the Company’s uncertain tax positions. In May 2024, the IRS initiated an audit for the years 2019 through 2021. On August 16, 2022, the Inflation Reduction Act of 2022 (“IRA”) was enacted, which among other things, implements a 15% minimum tax on book income of certain large corporations effective for years beginning after December 31, 2022. Based on the Company’s analysis, as well as guidance published by the IRS, the IRA, and in particular the 15% minimum tax, did not have an impact on the Company’s Consolidated Financial Statements. The Company will continue to evaluate the potential impact of this law as additional guidance and clarification becomes available. Additionally, on December 15, 2022, the 27 member states of the European Union (“EU”) reached an agreement on a minimum level of taxation for certain large corporations to pay a minimum corporate tax rate of 15% in every jurisdiction in which they operate. This agreement, which is known as the Minimum Tax Directive (part of the “Pillar II Model Rules”), was supposed to be transposed into the laws of all EU member states by December 31, 2023. Most member states complied, while some were granted extensions of time. In addition, many other jurisdictions outside the EU have also committed to implement this Directive while others have implemented a similar minimum tax regime consistent with the policy of the Pillar II Model Rules. This Directive does not have a material impact on the Company’s Consolidated Financial Statements. During the quarter ended June 30, 2023, the Company reassessed with its legal and tax advisers certain tax deductions taken in prior years by one of our subsidiaries and concluded that it was more likely than not that the deductions would not be sustained by the courts in that jurisdiction. The value of the tax deductions was not material to the Company in any year in which they were taken. The cumulative effect of the change in tax position of $148 was reflected as a discrete item in the quarter ended June 30, 2023 income tax expense, partially offset by the reversal of certain prior years’ withholding tax reserves of $22 that were no longer required. The tax liability was paid in the quarter ended September 30, 2023.
|
Pay vs Performance Disclosure - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Pay vs Performance Disclosure | ||||
Net Income (Loss) Attributable to Parent | $ 731 | $ 502 | $ 1,414 | $ 874 |
Insider Trading Arrangements |
3 Months Ended |
---|---|
Jun. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Use of Estimates (Policies) |
6 Months Ended |
---|---|
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.
|
Recent Accounting Pronouncements | Recent Accounting Pronouncements and Disclosure Rules In March 2024, the SEC finalized rules intended to enhance and standardize climate-related disclosures in registrants’ registration statements and Annual Reports on Form 10-K. The new rules would require climate-related disclosures, including as they relate to governance, strategy, risk management, targets and goals and greenhouse gas emissions. In addition, the rules would require certain climate-related disclosures as it relates to severe weather events and other natural conditions and carbon offsets and renewable energy credits. In April 2024, the SEC voluntarily stayed the rules due to pending judicial review. As these rules only impact disclosures, they will not have a material impact on the Company’s Consolidated Financial Statements. In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU improves the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the rate reconciliation, and income taxes paid disaggregated by jurisdiction. This guidance is effective for the Company for fiscal years beginning after December 15, 2024. As this accounting standard only impacts disclosures, it will not have a material impact on the Company’s Consolidated Financial Statements. In December 2023, the FASB issued ASU No. 2023-08, “Intangibles-Goodwill and Other-Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets.” This ASU improves the accounting for certain crypto assets by requiring companies to measure them at fair value for each reporting period with changes in fair value recognized in net income. This guidance is effective for the Company for fiscal years beginning after December 15, 2024 and is not expected to have an impact on the Company’s Consolidated Financial Statements. In November 2023, the FASB issued ASU No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU modified the disclosure and presentation requirements primarily through enhanced disclosures of significant segment expenses and other segment items. This guidance is effective for the Company for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. As this accounting standard only impacts disclosures, it will not have a material impact on the Company’s Consolidated Financial Statements. In October 2023, the FASB issued ASU No. 2023-06, “Disclosure Improvements-Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative.” This ASU modified the disclosure and presentation requirements of a variety of codification topics by aligning them with the SEC’s regulations. This guidance is effective for the Company no later than June 30, 2027 and is not expected to have a material impact on the Company’s Consolidated Financial Statements. In August 2023, the FASB issued ASU No. 2023-05, “Business Combinations-Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement.” This ASU requires a joint venture to initially measure all contributions received upon its formation at fair value. This guidance is applicable to joint ventures with a formation date on or after January 1, 2025 and is not expected to have a material impact on the Company’s Consolidated Financial Statements. In March 2023, the FASB issued ASU No. 2023-01, “Leases (Topic 842): Common Control Arrangements.” This ASU clarified the accounting for leasehold improvements for leases under common control. The guidance was effective for the Company beginning on January 1, 2024 and did not have a material impact on the Company’s Consolidated Financial Statements. In September 2022, the FASB issued ASU No. 2022-04, “Liabilities-Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” This ASU requires a buyer that uses supplier finance programs to make annual disclosures about the programs’ key terms, the balance sheet presentation of related amounts, the confirmed amount outstanding at the end of the period and associated roll-forward information. The Company adopted the guidance beginning on January 1, 2023, and with respect to the roll-forward information disclosure, beginning on January 1, 2024. See Note 12, Supplier Finance Program for additional information.
|
Restructuring and Related Implementation Charges (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Restructuring and Related Costs | For the six months ended June 30, 2024 and June 30, 2023, charges resulting from the 2022 Global Productivity Initiative are reflected in the income statement as follows:
The following table summarizes the activity for the restructuring and related implementation charges discussed above and the related accruals:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Percent of Total Restructuring Charges Related To Segment for the period | Total charges incurred for the 2022 Global Productivity Initiative relate to initiatives undertaken by the following reportable operating segments and Corporate:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cumulative Pretax Restructuring Charges | Since the inception of the 2022 Global Productivity Initiative, the Company has incurred cumulative pretax charges of $205 ($165 aftertax) in connection with the implementation of various projects as follows:
|
Inventories (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventory, Net, Items Net of Reserve Alternative [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Inventories by Major Class | Inventories by major class were as follows:
|
Earnings Per Share (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Earnings Per Share, Basic and Diluted | For the three months ended June 30, 2024 and 2023, earnings per share were as follows:
For the six months ended June 30, 2024 and 2023, earnings per share were as follows:
|
Other Comprehensive Income (Loss) (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Comprehensive Income (Loss) | Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three and six months ended June 30, 2024 and 2023 were as follows:
(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details. (2) These (gains) losses are reclassified into Cost of sales. See Note 11, Fair Value Measurements and Financial Instruments for additional details.
|
Retirement Plans and Other Retiree Benefits (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Components of Net Periodic Benefit Cost | Components of Net periodic benefit cost for the three and six months ended June 30, 2024 and 2023 were as follows:
|
Segment Information (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Sales and Operating Profit by Segment | Net sales by segment were as follows:
The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
Operating profit by segment was as follows:
Note: Table may not sum due to rounding.
|
Fair Value Measurements and Financial Instruments (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value of Derivative Instruments and Other Financial Instruments | The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Condensed Consolidated Balance Sheets at June 30, 2024 and December 31, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Notional Values | The following tables present the notional values as of:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Gains (Losses) Recognized in Statements of Income | The following table presents the location and amount of gain (loss) on fair value hedges recognized in the Company’s Condensed Consolidated Statements of Income:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) | The following tables present the amount of gain (loss) on cash flow hedges recognized in the Company’s Accumulated Other Comprehensive Income (AOCI) and reclassification from AOCI into the Condensed Consolidated Statements of Income:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) | The following table presents the amount of gain (loss) on net investment hedges recognized in the Company’s AOCI:
|
Restructuring and Related Implementation Charges - Schedule of Restructuring Charges, Cumulative to Date (Details) - Global Productivity Initiative $ in Millions |
Jun. 30, 2024
USD ($)
|
---|---|
Restructuring Cost and Reserve [Line Items] | |
Pretax charges related to the restructuring program to date | $ 205 |
Restructuring and related cost incurred cost to date after tax | 165 |
Employee-Related Costs | |
Restructuring Cost and Reserve [Line Items] | |
Pretax charges related to the restructuring program to date | 175 |
Incremental Depreciation | |
Restructuring Cost and Reserve [Line Items] | |
Pretax charges related to the restructuring program to date | 7 |
Asset Impairments | |
Restructuring Cost and Reserve [Line Items] | |
Pretax charges related to the restructuring program to date | 1 |
Other | |
Restructuring Cost and Reserve [Line Items] | |
Pretax charges related to the restructuring program to date | $ 22 |
Restructuring and Related Implementation Charges - Schedule of Restructuring Activity and Related Accruals (Details) - Global Productivity Initiative $ in Millions |
6 Months Ended |
---|---|
Jun. 30, 2024
USD ($)
| |
Restructuring Reserve [Roll Forward] | |
Balance | $ 11 |
Charges | 63 |
Cash Payments | (15) |
Charges against assets | (7) |
Foreign exchange | (1) |
Balance | 51 |
Employee-Related Costs | |
Restructuring Reserve [Roll Forward] | |
Balance | 10 |
Charges | 49 |
Cash Payments | (10) |
Charges against assets | 0 |
Foreign exchange | (1) |
Balance | 48 |
Incremental Depreciation | |
Restructuring Reserve [Roll Forward] | |
Balance | 0 |
Charges | 7 |
Cash Payments | 0 |
Charges against assets | (7) |
Foreign exchange | 0 |
Balance | 0 |
Asset Impairments | |
Restructuring Reserve [Roll Forward] | |
Balance | 0 |
Charges | 0 |
Cash Payments | 0 |
Charges against assets | 0 |
Foreign exchange | 0 |
Balance | 0 |
Other | |
Restructuring Reserve [Roll Forward] | |
Balance | 1 |
Charges | 7 |
Cash Payments | (5) |
Charges against assets | 0 |
Foreign exchange | 0 |
Balance | $ 3 |
Inventories - Schedule of Inventories by Major Class (Details) - USD ($) $ in Millions |
Jun. 30, 2024 |
Dec. 31, 2023 |
---|---|---|
Inventory, Net, Items Net of Reserve Alternative [Abstract] | ||
Raw materials and supplies | $ 613 | $ 606 |
Work-in-process | 43 | 46 |
Finished goods | 1,398 | 1,411 |
Total Inventories, net | 2,054 | 2,063 |
Non-current inventory, net | (132) | (129) |
Current Inventories, net | $ 1,922 | $ 1,934 |
Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Net income attributable to Colgate-Palmolive Company | ||||
Basic EPS | $ 731 | $ 502 | $ 1,414 | $ 874 |
Diluted EPS | $ 731 | $ 502 | $ 1,414 | $ 874 |
Shares (millions) | ||||
Basic EPS (in shares) | 819.7 | 829.4 | 821.3 | 830.4 |
Stock options and restricted stock units (in shares) | 4.0 | 1.9 | 3.6 | 1.7 |
Diluted EPS (in shares) | 823.7 | 831.3 | 824.9 | 832.1 |
Per Share | ||||
Basic EPS (in dollars per share) | $ 0.89 | $ 0.61 | $ 1.72 | $ 1.05 |
Diluted EPS (in dollars per share) | $ 0.89 | $ 0.60 | $ 1.71 | $ 1.05 |
Earnings Per Share - Narrative (Details) - shares |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Earnings Per Share [Abstract] | ||||
Antidilutive securities excluded from computation of earnings per share (in shares) | 14,865 | 6,268,944 | 23,044 | 13,482,312 |
Other Comprehensive Income (Loss) - Schedule of Comprehensive Income (Loss) (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Total Other comprehensive income (loss), net of tax | $ (110) | $ 23 | $ (199) | $ 79 | |||||||
Accumulated Other Comprehensive Income (Loss) | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Total Other comprehensive income (loss), net of tax | (109) | [1] | 48 | [1] | (191) | 120 | [2] | ||||
Cumulative translation adjustments, pre-tax | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Other comprehensive income (loss), pretax | (94) | 57 | (165) | 106 | |||||||
Tax amounts | (23) | (5) | (39) | 5 | |||||||
Total Other comprehensive income (loss), net of tax | (117) | 52 | (204) | 111 | |||||||
Retirement Plan and other retiree benefit adjustments, net of tax | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Other comprehensive income (loss), before reclassifications, pretax | 0 | (1) | (1) | 0 | |||||||
Reclassification from AOCI, pretax | 6 | 8 | 15 | 16 | |||||||
Other comprehensive income (loss), pretax | 6 | 7 | 14 | 16 | |||||||
Tax amounts | 0 | (1) | (3) | (3) | |||||||
Total Other comprehensive income (loss), net of tax | 6 | 6 | 11 | 13 | |||||||
Gains (losses) on cash flow hedges, net of tax | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Other comprehensive income (loss), before reclassifications, pretax | 1 | (17) | 1 | 0 | |||||||
Reclassification from AOCI, pretax | 1 | 3 | 1 | (6) | |||||||
Other comprehensive income (loss), pretax | 2 | (14) | 2 | (6) | |||||||
Tax amounts | 0 | 4 | 0 | 2 | |||||||
Total Other comprehensive income (loss), net of tax | $ 2 | $ (10) | $ 2 | $ (4) | |||||||
|
Retirement Plans and Other Retiree Benefits - Schedule of Components of Net Periodic Benefit Cost (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |||
---|---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Components of net periodic benefit cost | |||||
ERISA litigation matter | $ 267,000,000 | $ 0 | $ 267,000,000 | ||
Employee-Related Costs | Global Productivity Initiative | |||||
Components of net periodic benefit cost | |||||
Other postretirement charges | $ 3,000,000 | 4,000,000 | |||
Other Retiree Benefits | |||||
Components of net periodic benefit cost | |||||
Service cost | $ 2,000,000 | 2,000,000 | 4,000,000 | 4,000,000 | |
Interest cost | 11,000,000 | 11,000,000 | 19,000,000 | 22,000,000 | |
Expected return on plan assets | 0 | 0 | 0 | 0 | |
Amortization of actuarial loss (gain) | (5,000,000) | (4,000,000) | (8,000,000) | (8,000,000) | |
Net periodic benefit cost | 8,000,000 | 9,000,000 | 15,000,000 | 18,000,000 | |
Other postretirement charges | 0 | 0 | 0 | 0 | |
ERISA litigation matter | 0 | 0 | |||
Total pension cost | 8,000,000 | 9,000,000 | 15,000,000 | 18,000,000 | |
United States | Pension Benefits | |||||
Components of net periodic benefit cost | |||||
Service cost | 0 | 0 | 0 | 0 | |
Interest cost | 24,000,000 | 25,000,000 | 47,000,000 | 48,000,000 | |
Expected return on plan assets | (20,000,000) | (21,000,000) | (39,000,000) | (41,000,000) | |
Amortization of actuarial loss (gain) | 11,000,000 | 11,000,000 | 21,000,000 | 22,000,000 | |
Net periodic benefit cost | 15,000,000 | 15,000,000 | 29,000,000 | 29,000,000 | |
Other postretirement charges | 0 | 3,000,000 | 0 | 4,000,000 | |
ERISA litigation matter | 0 | 267,000,000 | |||
Total pension cost | 15,000,000 | 18,000,000 | 29,000,000 | 300,000,000 | |
Voluntary benefit plan contribution | 0 | 0 | |||
International | Pension Benefits | |||||
Components of net periodic benefit cost | |||||
Service cost | 5,000,000 | 3,000,000 | 8,000,000 | 6,000,000 | |
Interest cost | 7,000,000 | 8,000,000 | 15,000,000 | 16,000,000 | |
Expected return on plan assets | (6,000,000) | (5,000,000) | (13,000,000) | (9,000,000) | |
Amortization of actuarial loss (gain) | 0 | 1,000,000 | 2,000,000 | 2,000,000 | |
Net periodic benefit cost | 6,000,000 | 7,000,000 | 12,000,000 | 15,000,000 | |
Other postretirement charges | 0 | 0 | 0 | 0 | |
ERISA litigation matter | 0 | 0 | |||
Total pension cost | $ 6,000,000 | $ 7,000,000 | $ 12,000,000 | $ 15,000,000 |
Segment Information - Narrative (Details) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2024
USD ($)
|
Jun. 30, 2023
USD ($)
|
Jun. 30, 2024
USD ($)
segment
|
Jun. 30, 2023
USD ($)
|
|
Segment Reporting Information [Line Items] | ||||
Number of product segments (in segments) | segment | 2 | |||
Number of geographically reportable operating segments (in segments) | segment | 5 | |||
Corporate | Included in Operating profit (loss) | Global Productivity Initiative | ||||
Segment Reporting Information [Line Items] | ||||
Restructuring costs | $ | $ 27 | $ 18 | $ 63 | $ 23 |
Corporate | Included in Operating profit (loss) | Product Recall Cost | ||||
Segment Reporting Information [Line Items] | ||||
Restructuring costs | $ | $ 25 | |||
Net Sales | ||||
Segment Reporting Information [Line Items] | ||||
Percentage of consolidated Net sales represented by sales outside US | 66.67% | 66.67% | ||
Percentage of consolidated Net sales coming from emerging markets | 45.00% | 45.00% |
Fair Value Measurements and Financial Instruments - Narrative (Details) - USD ($) $ in Millions |
6 Months Ended | |
---|---|---|
Jun. 30, 2024 |
Dec. 31, 2023 |
|
Debt Instrument [Line Items] | ||
Derivative, term of contract | 12 months | |
Carrying Value | ||
Debt Instrument [Line Items] | ||
Carrying value of long-term debt | $ 8,167 | $ 8,239 |
Fair Value, Inputs, Level 2 | ||
Debt Instrument [Line Items] | ||
Estimated fair value of long-term debt | $ 7,575 | $ 7,862 |
Fair Value Measurements and Financial Instruments - Schedule of Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($) $ in Millions |
Jun. 30, 2024 |
Dec. 31, 2023 |
---|---|---|
Designated derivative instruments | ||
Derivative assets | $ 48 | $ 19 |
Derivative liabilities | $ 16 | $ 26 |
Derivative Asset, Statement of Financial Position [Extensible Enumeration] | Other current assets | Other current assets |
Derivative Liability, Statement of Financial Position [Extensible Enumeration] | Other accruals | Other accruals |
Other financial instruments | ||
Total other financial instruments | $ 225 | $ 179 |
Foreign currency contracts | ||
Designated derivative instruments | ||
Derivative assets | 48 | 19 |
Derivative liabilities | 13 | 25 |
Commodity contracts | ||
Designated derivative instruments | ||
Derivative assets | 0 | 0 |
Derivative liabilities | 3 | 1 |
Other current assets | ||
Other financial instruments | ||
Marketable securities | $ 225 | $ 179 |
Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) - Net Investment Hedges - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Net investment hedges [Abstract] | ||||
Total gain (loss) on net investment hedges | $ 50 | $ 139 | $ 158 | $ 58 |
Foreign currency contracts | ||||
Net investment hedges [Abstract] | ||||
Total gain (loss) on net investment hedges | 22 | 26 | 24 | 18 |
Foreign Currency Debt | ||||
Net investment hedges [Abstract] | ||||
Total gain (loss) on net investment hedges | $ 28 | $ 113 | $ 134 | $ 40 |
Income Taxes (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Income Tax Disclosure [Abstract] | ||||
Effective income tax rate (percent) | 24.10% | 39.80% | ||
Effective income tax rate, full year (percent) | 24.30% | 24.80% | ||
Estimated tax plus interest | $ 150 | |||
Cumulative effect of change in tax position | $ 148 | |||
Withholding tax reserves, prior year reversals | $ 22 |
\)QWLN/LL-I0H]U163UZ.-4MLKSY/+#:V)O.1;RN#-BHN:*+@5:T]N!25%
M$U177N#[B5>3DHTFX^;9O9B,^4Y5):/W LE=71/QY896?'\]PJ/G!Q_+]4;I
M!]YDO"5K^D#5I^V]@#NOSU*4-66RY P)NKH>?N3K&=&*+I5.0>#GD4YI5>E,,(]_NJ2C?DP=>'S]G/W'ACR061!)
MI[SZLRS4YGJ4C5!!5V17J8]\_S/M",4ZWY)7LOF+]BTV ?!R)Q6ONV"805VR
M]I<\=4(=T#0!01F0'0F(.P"PM>.$'4!T6M'B+N AKK7 6B0,K4]'YPFQ001('2[%758$>];BI.<5"?/JV4PE-I)H,ESR
MN8Q2WQ#VV"+/V7$=>\@VE #GUH1V6>'$H[ G%WG.INN80GLWA9/I7C792G29
MQ=X9W9.&A/==MPNF^$**DBO]ZA?(G>PM^A66S>;1*?9%-UTOU=IAZ#V^R+%]
M5UT#M;21Q; "&>O%M"OU:UP<7"EZX*'^1$L[-?!ZE'"GVCRA1VD#KX?(
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M1SFW#: I0R@M0M'Z"NSJ]\)CP_L=Z%VKF4C
M'-X8]4T65"VBJP@*+$6KZ-YT'W&HY\+SY4:Y\(6NCYURQKQU9.H!S/-:ZOXO
M]L,Y' &NDE< Z0!(@^X^45#Y09#(YM9T8'TTL_E!*#6@69S4_E(>R/*N9!QE
MCP[!E'#K2'*)Z.8Q,:O?B_.!8=4SI*\P7,(7HZER<*L++/[$QZQFE)0>)*W2
MDX2?6SV!:7(&:9+.3O!-QQ*G@6_Z"M\RSTVK2>HMK(V2N40'WY<;1Y:?Q(^7
M"N[Y9B_S>9M_:IR0RHJ]0MO:9E
MI3TD"8NX27'DD6F1P0I(/;HG8-I_T(KWGKQXL+=QYO('U9@/E4Q?ECHL&)*-
M#D[&][5Z-KM^F4,\OQQP)/.^*%)99H7#!6"AJDZX]!RZ>*2]- =+LZ9[H_!\G2B)R;L$=.")R857-B/MM?:+XO"*9U
M5CO_31B8M!BXKG&@5(YD%'-P9NO[;PS21?P&UN3_U\T